Ondansetron Tillomed (Ondansetron Hydrochloride Dihydrate)

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Tillomed, is a 5-HT3 receptor antagonist presented as an intravenous solution for injection use. It treats and helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron Tillomed is a selective 5‑HT3 receptor antagonist that works within the serotonin pathway to control nausea and vomiting. - Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: helps control nausea during and after radiotherapy. - Post‑operative nausea and vomiting: decreases the incidence of nausea and vomiting after surgical procedures. - Pregnancy‑related nausea (off‑label): may be used when benefits outweigh risks, under specialist specialist specialist specialist specialist specialist specialist specialist . - Post‑viral